Mahkam Zanganeh, Co-CEO: Summit Therapeutics SMMT Buy · Filed 25/09/11

Trade details

Type: Insider buy
Amount: $90,350
Shares · price: 5,000 sh · $18.07 a share
Held after: 556,093,090 sh
Stock: Summit Therapeutics SMMT
Person: Mahkam ZanganehCo-CEO
Trade date: 25/09/11
Filed: 25/09/11
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: under 0.1%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/12~25/10/11

Mahkam Zanganeh's recent trades

Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$50M
3,810,000 sh
$50M
Filed 06/12
Traded 06/12
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$500K
26,680 sh
$500K
Filed 25/10/23
Traded 25/10/21
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$5.9M
333,394 sh
$5.9M
Filed 25/09/11
Traded 25/09/10
Mahkam ZanganehCEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$127.7K
34,321 sh
$127.7K
Filed 24/03/27
Traded 24/03/27

Mahkam Zanganeh, CEO — bought $90.3K of Summit Therapeutics SMMT · 5,000 sh @ $18.07 | Whalegun